Quality of administration of intranasal steroid sprays in patient in rhinology clinic in HRH Princess Maha Chakri Sirindhorn Medical Center

Completed

• Conditions: Quality of administration of intranasal steroid sprays; Intranasal steroid Quality of administration Allergic rhinitis

• Registration Number: TCTR20210718003
• Lead Sponsor: HRH Princess Maha Chakri Siridhorn Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-07-01
• Study Start: 2021-07-18
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

1. Age 18-60 years
2. Confirm diagnosis of Allergic rhinitis, Chronic rhinosinusitis with out nasal polyp, Chronic rhinosinusitis with nasal polyp in HRH Princess Maha Chakri Siridhorn Medical Center
3. Use intranasal steroid for more than 1 week

Exclusion Criteria

1. Unable to communicate in thai language
2. Allergy to intranasal steroid
3. Contraindicated for intranasal steroid use ex. glaucoma, pulmonary tuberculosis, fungal infection
4. Pregnancy

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of administration of intranasal steroid sprays At least 1 week after using intranasal steroid 12 step for using intranasal steroid

Secondary Outcome Measures

Name	Time	Method
complication after using intranasal steroid within one year after start using intranasal steroid number of patients with complications